Spotlight on Breast Cancer Research
Breast Cancer Awareness Month is still in full swing. In recognition of this important health issue, we highlight here several…
Breast Cancer
Assessment and management of benign breast lesions: Role of the WHNP
“Benign Breast Conditions: The Role of the WHNP,” will be a breakout session at the 24th Annual NPWH Premier Women’s Health Conference Oct. 13 to 16. See article for registration details.
Implementing a Cancer Risk Assessment Screening Tool: Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer Syndrome
The development and implementation of an HBOC risk assessment protocol can decrease morbidity and mortality.
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting…
Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…